About the Authors
- Liu He
-
Contributed equally to this work with: Liu He, Xiaolan Xu
Affiliation Institute of Medicinal Plant Development (IMPLAD), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Xiaolan Xu
-
Contributed equally to this work with: Liu He, Xiaolan Xu
Affiliation Institute of Medicinal Plant Development (IMPLAD), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Ying Li
-
Affiliation Institute of Medicinal Plant Development (IMPLAD), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Chunfang Li
-
Affiliation Institute of Medicinal Plant Development (IMPLAD), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Yingjie Zhu
-
Affiliation Institute of Medicinal Plant Development (IMPLAD), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Haixia Yan
-
Affiliation Institute of Medicinal Plant Development (IMPLAD), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Zhiying Sun
-
Affiliation Institute of Medicinal Plant Development (IMPLAD), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Chao Sun
-
Affiliation Institute of Medicinal Plant Development (IMPLAD), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Jingyuan Song
-
Affiliation Institute of Medicinal Plant Development (IMPLAD), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Yu’an Bi
-
Affiliation State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process; Jiangsu Kanion Pharmaceutical Co. LTD, Lianyungang, China
- Juan Shen
-
Affiliation State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process; Jiangsu Kanion Pharmaceutical Co. LTD, Lianyungang, China
- Ruiyang Cheng
-
Affiliation Beijing University of Chinese Medicine, Beijing, China
- Zhenzhong Wang
-
Affiliation State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process; Jiangsu Kanion Pharmaceutical Co. LTD, Lianyungang, China
- Wei Xiao
-
* E-mail: wzhzh-nj@tom.com (WX); slchen@implad.ac.cn (SC)
Affiliation State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process; Jiangsu Kanion Pharmaceutical Co. LTD, Lianyungang, China
- Shilin Chen
-
* E-mail: wzhzh-nj@tom.com (WX); slchen@implad.ac.cn (SC)
Affiliations Institute of Medicinal Plant Development (IMPLAD), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, Institute of Chinese Materia Medica, Academy of Chinese Medical Sciences, Beijing, China
Competing Interests
Four authors (YB, J. Shen, ZW and WX) are employed in Jiangsu Kanion Pharmaceutical Co. LTD. All the authors are cooperation partners in this study about transcriptome analysis of L. japonica. There are no competing interests in employment, consultancy, patents, products in development or marketed products etc. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: SC WX J. Song CS ZW. Performed the experiments: LH XX CL. Analyzed the data: YL YZ RC. Contributed reagents/materials/analysis tools: LH HY ZS YB J. Shen. Wrote the paper: LH XX.